A detailed history of Simplex Trading, LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 203,502 shares of BLUE stock, worth $75,295. This represents 0.0% of its overall portfolio holdings.

Number of Shares
203,502
Previous 312,625 34.91%
Holding current value
$75,295
Previous $306,000 65.69%
% of portfolio
0.0%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$0.47 - $1.35 $51,287 - $147,316
-109,123 Reduced 34.91%
203,502 $105,000
Q2 2024

Jul 25, 2024

BUY
$0.85 - $1.26 $44,268 - $65,620
52,080 Added 19.99%
312,625 $306,000
Q1 2024

Apr 25, 2024

BUY
$0.91 - $1.75 $6,623 - $12,738
7,279 Added 2.87%
260,545 $333,000
Q4 2023

Feb 02, 2024

BUY
$1.32 - $4.83 $3,380 - $12,369
2,561 Added 1.02%
253,266 $349,000
Q3 2023

Nov 01, 2023

BUY
$3.02 - $4.05 $34,470 - $46,226
11,414 Added 4.77%
250,705 $762,000
Q2 2023

Aug 04, 2023

SELL
$2.79 - $5.03 $117,503 - $211,843
-42,116 Reduced 14.97%
239,291 $787,000
Q1 2023

Apr 27, 2023

BUY
$3.14 - $8.22 $457,513 - $1.2 Million
145,705 Added 107.37%
281,407 $894,000
Q4 2022

Feb 02, 2023

SELL
$5.77 - $8.49 $142,772 - $210,076
-24,744 Reduced 15.42%
135,702 $939,000
Q3 2022

Nov 04, 2022

BUY
$3.75 - $7.39 $52,271 - $103,009
13,939 Added 9.51%
160,446 $1.02 Million
Q2 2022

Aug 03, 2022

BUY
$2.94 - $5.23 $369,493 - $657,295
125,678 Added 603.38%
146,507 $606,000
Q1 2022

May 02, 2022

SELL
$4.07 - $10.6 $89,865 - $234,048
-22,080 Reduced 51.46%
20,829 $101,000
Q4 2021

Feb 23, 2022

BUY
$8.96 - $16.31 $38,474 - $70,035
4,294 Added 11.12%
42,909 $428,000
Q3 2021

Oct 28, 2021

BUY
$11.24 - $21.0 $30,156 - $56,343
2,683 Added 7.47%
38,615 $1.25 Million
Q2 2021

Aug 12, 2021

SELL
$18.04 - $22.09 $830,669 - $1.02 Million
-46,046 Reduced 56.17%
35,932 $1.15 Million
Q1 2021

Apr 26, 2021

BUY
$16.59 - $33.89 $469,098 - $958,273
28,276 Added 52.65%
81,978 $2.47 Million
Q4 2020

Feb 02, 2021

BUY
$27.5 - $37.92 $587,400 - $809,971
21,360 Added 66.04%
53,702 $2.32 Million
Q3 2020

Oct 14, 2020

BUY
$34.44 - $43.75 $434,081 - $551,425
12,604 Added 63.86%
32,342 $1.74 Million
Q2 2020

Jul 13, 2020

SELL
$27.12 - $45.97 $179,914 - $304,964
-6,634 Reduced 25.16%
19,738 $780,000
Q1 2020

Apr 29, 2020

BUY
$26.16 - $63.5 $19,986 - $48,514
764 Added 2.98%
26,372 $1.21 Million
Q4 2019

Feb 05, 2020

BUY
$46.96 - $61.67 $944,882 - $1.24 Million
20,121 Added 366.7%
25,608 $2.25 Million
Q3 2019

Oct 15, 2019

BUY
$59.47 - $93.1 $326,311 - $510,839
5,487 New
5,487 $326,000
Q2 2019

Jul 26, 2019

SELL
$75.84 - $105.21 $208,711 - $289,537
-2,752 Closed
0 $0
Q1 2019

Apr 18, 2019

SELL
$64.44 - $104.11 $391,215 - $632,051
-6,071 Reduced 68.81%
2,752 $0
Q4 2018

Jan 16, 2019

BUY
$59.1 - $93.26 $521,439 - $822,832
8,823 New
8,823 $875,000
Q3 2018

Oct 23, 2018

SELL
$88.86 - $117.49 $2.04 Million - $2.7 Million
-23,011 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$99.64 - $127.59 $2.28 Million - $2.92 Million
22,911 Added 22911.0%
23,011 $3.61 Million
Q1 2018

Apr 26, 2018

BUY
$105.8 - $150.94 $10,580 - $15,094
100 New
100 $17,000
Q4 2017

Jan 10, 2018

SELL
$81.25 - $130.7 $572,406 - $920,781
-7,045 Closed
0 $0
Q3 2017

Oct 25, 2017

BUY
$57.74 - $91.42 $406,778 - $644,053
7,045
7,045 $967,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $28.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.